HK1192904A1 - 用於癒合或治療傷口的分子靶標 - Google Patents

用於癒合或治療傷口的分子靶標

Info

Publication number
HK1192904A1
HK1192904A1 HK14106417.6A HK14106417A HK1192904A1 HK 1192904 A1 HK1192904 A1 HK 1192904A1 HK 14106417 A HK14106417 A HK 14106417A HK 1192904 A1 HK1192904 A1 HK 1192904A1
Authority
HK
Hong Kong
Prior art keywords
healing
molecular targets
treating wounds
wounds
treating
Prior art date
Application number
HK14106417.6A
Other languages
English (en)
Inventor
姜文國
基斯．哈丁
Original Assignee
加的夫大學學院諮詢有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 加的夫大學學院諮詢有限公司 filed Critical 加的夫大學學院諮詢有限公司
Publication of HK1192904A1 publication Critical patent/HK1192904A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/31—Combination therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK14106417.6A 2011-03-08 2014-06-25 用於癒合或治療傷口的分子靶標 HK1192904A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1103898.1A GB201103898D0 (en) 2011-03-08 2011-03-08 Molecular targets for healing or treating wounds
PCT/GB2012/050362 WO2012120269A1 (en) 2011-03-08 2012-02-17 Molecular targets for healing or treating wounds

Publications (1)

Publication Number Publication Date
HK1192904A1 true HK1192904A1 (zh) 2014-09-05

Family

ID=43923365

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14106417.6A HK1192904A1 (zh) 2011-03-08 2014-06-25 用於癒合或治療傷口的分子靶標

Country Status (10)

Country Link
US (2) US20140213629A1 (zh)
EP (1) EP2683823B1 (zh)
JP (1) JP5986116B2 (zh)
CN (1) CN103443276B (zh)
AU (1) AU2012226593B2 (zh)
CA (1) CA2829010A1 (zh)
GB (2) GB201103898D0 (zh)
HK (1) HK1192904A1 (zh)
IN (1) IN2013MN01547A (zh)
WO (1) WO2012120269A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014183062A1 (en) 2013-05-10 2014-11-13 La Jolla Institute For Allergy And Immunology Autoimmune disease treatments
WO2015019125A1 (en) * 2013-08-05 2015-02-12 Societe De Developpement Et De Recherche Industrielle Molecular targets for the treatment of wounds, in particular chronic wounds
US20220143210A1 (en) * 2019-02-27 2022-05-12 Fred Hutchinson Cancer Research Center Hydrogel compositions and methods for treatement of malignancies

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204000B1 (en) 1995-04-28 2001-03-20 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
KR100366439B1 (ko) * 2000-02-21 2003-01-09 주식회사 대웅 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물
US20050215629A1 (en) 2001-09-07 2005-09-29 Taolin Yi PTPase inhibitors and methods of using the same
AU2002339904A1 (en) * 2001-09-07 2003-09-09 The Cleveland Clinic Foundation Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
US7844214B2 (en) 2002-03-02 2010-11-30 Nokia Corporation System and method for broadband digital broadcasting
EP1482966B1 (en) * 2002-03-12 2014-05-14 Bio-Click Technologies Ltd Method and composition for treating skin wounds with epidermal growth factor
US20040009597A1 (en) * 2002-07-03 2004-01-15 Isis Pharmaceuticals Inc. Antisense modulation of PTPRK expression
CA2506619A1 (en) 2002-11-18 2004-08-19 Thomas W. Hodge Cell lines and host nucleic acid sequences related to infectious disease
JP2006517092A (ja) 2002-11-27 2006-07-20 アルテシアン セラピューティック，インコーポレイティド 心不全遺伝子の決定及び治療薬スクリーニング
GB2396106B (en) * 2002-12-12 2006-11-15 Johnson & Johnson Medical Ltd Wound dressings comprising enzyme inhibitors
AU2004274973A1 (en) 2003-09-19 2005-03-31 Aviaradx, Inc. Predicting breast cancer treatment outcome
US20050170445A1 (en) 2004-01-07 2005-08-04 Duke University Methods of establishing profiles for use in evaluating wound healing and biocompatibility of implant materials and microarrays useful therefor
WO2006108225A1 (en) 2005-04-11 2006-10-19 Garvan Institute Of Medical Research Method of screening for compounds that modulate cell proliferation
US20090203006A1 (en) 2006-05-01 2009-08-13 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Biological markers of chronic wound tissue and methods of using for criteria in surgical debridement
WO2008005276A2 (en) * 2006-06-30 2008-01-10 Directcontact Llc Growth factor delivery system containing antimicrobial agents
EP2242852A4 (en) 2007-12-07 2011-02-09 Univ Oregon Health & Science PROCEDURE FOR DETERMINING WHETHER AN INDIVIDUAL REQUIRES A BCR ABL INHIBITOR
US20110305703A1 (en) 2008-12-08 2011-12-15 Vegenics Pty Limited Isolated vegf-c and vegf-d peptides and uses thereof
US20120190042A1 (en) 2009-01-22 2012-07-26 Reuben Gobezie Protein biomarkers and therapeutic targets for osteoarthritis
CN101671729B (zh) 2009-09-07 2012-09-05 张力建 用于肺癌治疗方案选择和/或预后评估的基因群、基因芯片和检测试剂盒
GB0916124D0 (en) 2009-09-15 2009-10-28 Univ Cardiff Method and kit for the classification and prognosis of wounds

Also Published As

Publication number Publication date
EP2683823B1 (en) 2016-07-20
US20140213629A1 (en) 2014-07-31
WO2012120269A1 (en) 2012-09-13
CN103443276A (zh) 2013-12-11
JP2014511392A (ja) 2014-05-15
GB201103898D0 (en) 2011-04-20
GB2502017A (en) 2013-11-13
CA2829010A1 (en) 2012-09-13
GB201314859D0 (en) 2013-10-02
US20160331716A1 (en) 2016-11-17
CN103443276B (zh) 2016-09-28
AU2012226593A1 (en) 2013-09-12
US9782381B2 (en) 2017-10-10
EP2683823A1 (en) 2014-01-15
AU2012226593B2 (en) 2016-06-02
IN2013MN01547A (zh) 2015-06-12
JP5986116B2 (ja) 2016-09-06

Similar Documents

Publication Publication Date Title
ZA201308417B (en) Tissue healing
EP2755562B8 (en) Treatment catheter system
IL231509B (en) Tissue wound healing products
HK1207861A1 (zh) 作為 抑制劑的用於治療癌症的取代的環烯並吡唑
EP2555760A4 (en) METHODS AND COMPOSITIONS FOR TREATING INJURIES USING CHITOSAN COMPOUNDS
PL2838613T3 (pl) Układ medyczny do leczenia głębokich celów powierzchniowych
HK1198012A1 (zh) 用於治療瘻的組合物
ZA201309301B (en) Device for vacuum treatment of wounds
EP2858719A4 (en) Systems and methods for tissue treatment
IL225759A0 (en) Normal medical riveting system for shaping bones
EP2603222A4 (en) COMBINATIVE CANCER TREATMENT
EP2617445B8 (en) System for medical treatment
EP2688402A4 (en) METHODS FOR THE TREATMENT OR PREVENTION OF UROLOGIC INFLAMMATION
SG10201700525PA (en) Composition for preventing or treating osteoarthritis
HUE044796T2 (hu) Gyógyászati készítmény hiperkoleszterinémia kezelésére
HK1192904A1 (zh) 用於癒合或治療傷口的分子靶標
EP2536282A4 (en) METHOD FOR THE TREATMENT OF INFECTIONS
EP2736512A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPITHELIAL WOUNDS
EP2632432A4 (en) COMPOSITION AND METHOD FOR TREATING LESIONS
GB201003652D0 (en) Molecular target for healing or treating wounds
LT2863931T (lt) Kompozicijos, skirtos panaudoti žaizdų gydymui
EP2826488A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS
PL2663318T3 (pl) Kompozycja farmaceutyczna do leczenia raka
GB201104082D0 (en) Molecular targets for healing or treating wounds
GB201103962D0 (en) Molecular targets for healing or treating wounds